Clinical TrialsSearch results
Number of results: 527
Recruiting
- PhaseII study of Atezolizumab plus Chemotherapy in PS 2 Patients With Non-Sq NSCLC
- Non-Sq non-small cell lung cancer
- Murakami Haruyasu
- 2021-06-10
Other
- Randomiazed controlled trial comparing docetaxel-cisplatin combination with docetaxel alone in elderly patients with advanced non-small-cell lung cancer(JCOG0207)
- non-small-cell lung cancer
- Japan Clinical Oncology Group(JCOG)
- 2005-09-09
Other
- Randomiazed controlled trial comparing docetaxel-cisplatin combination with docetaxel alone in elderly patients with advanced non-small-cell lung cancer(JCOG0803/WJOG4307L)
- non-small-cell lung cancer
- Japan Clinical Oncology Group(JCOG)
- 2008-10-10
Recruiting
- A Phase 1/2 Trial of CLN-081 in Patients With Locally-Advanced or Metastatic Non-Small Cell Lung Cancer
- Non-small cell lung cancer harboring EGFR exon 20 insertion mutations
- Nasermoaddeli Ali
- 2023-04-30
Other
- A Phase I Dose Intensification Study of three dimentional conformal thoracic radiotherapy with concurrent cisplatin and TS-1 for unresectable stage III non-small cell lung cancer
- non-small cell lung cancer
- Shizuoka Cancer Center, The Cancer Institute Hospital of JFCR
- 2008-12-02
Other
- A phase I study of vinorelbine concurrent with thoracic radiotherapy in elderly patients with l locally advanced non-small cell lung cancer(WJTOG 3005).
- Non-small cell lung cancer
- West Japan Oncology Group
- 2008-09-26
Other
- A phase II randomized trial in completely resected non-small cell lung cancer comparing paclitaxel / carboplatin with TS-1
- non-small cell lung cancer
- Nagoya City University thoracic oncology study group
- 2008-11-18
Other
- Outcome study of complete resections for p-N2 non-small cell lung cancer
- non-small cell lung cancer
- JMTO
- 2008-07-28
Other
- Phase I/II study of intermittent erlotinib in combination with docetaxel in patients with recurrent non-small cell lung cancer
- Non-small cell lung cancer
- West Japan Oncology Group
- 2009-03-17
Other
- Phase II study of gefitinib in patients with EGFR mutation positive- advanced non-small cell lung cancer
- non-small cell lung cancer
- West Japan Oncology Group
- 2005-09-09